Endoscopic radiofrequency ablation for malignant biliary obstruction
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F21%3A00081768" target="_blank" >RIV/00023001:_____/21:00081768 - isvavai.cz</a>
Alternative codes found
RIV/00098892:_____/21:N0000097
Result on the web
<a href="https://www.wjgnet.com/1948-5204/full/v13/i10/1383.htm" target="_blank" >https://www.wjgnet.com/1948-5204/full/v13/i10/1383.htm</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4251/wjgo.v13.i10.1383" target="_blank" >10.4251/wjgo.v13.i10.1383</a>
Alternative languages
Result language
angličtina
Original language name
Endoscopic radiofrequency ablation for malignant biliary obstruction
Original language description
Cholangiocarcinoma and pancreatic cancer are the most common causes of malignant biliary obstruction. The majority of patients are diagnosed at a late stage when surgical resection is rarely possible. In these cases, palliative chemotherapy and radiotherapy provide only limited benefit and are associated with poor survival. Radiofrequency ablation (RFA) is a procedure for locoregional control of tumours, whereby a high-frequency alternating current turned into thermal energy causes coagulative necrosis of the tissue surrounding the catheter. The subsequent release of debris and tumour antigens by necrotic cells can stimulate local and systemic immunity. The development of endoluminal RFA catheters has led to the emergence of endoscopically delivered RFA, a treatment mainly used for malignant biliary strictures to prolong survival and/or stent patency. Other indications include recanalisation of occluded biliary stents and treatment of intraductal ampullary adenoma or benign biliary strictures. This article presents a comprehensive review of endobiliary RFA, mainly focusing on its use in patients with malignant biliary obstruction. The available data suggest that biliary RFA may be a promising modality, having positive impacts on survival and stent patency and boasting a reasonable safety profile. However, further studies with better characterised and stratified patient populations are needed before the method becomes accepted within routine clinical practice. © 2021. The Author(s). Published by Baishideng Publishing Group Inc. All Rights Reserved.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30219 - Gastroenterology and hepatology
Result continuities
Project
<a href="/en/project/NV17-30281A" target="_blank" >NV17-30281A: Radiofrequency ablation in therapy of biliary and pancreatic disease</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
World journal of gastrointestinal oncology
ISSN
1948-5204
e-ISSN
—
Volume of the periodical
13
Issue of the periodical within the volume
10
Country of publishing house
US - UNITED STATES
Number of pages
14
Pages from-to
1383-1396
UT code for WoS article
000721601200010
EID of the result in the Scopus database
2-s2.0-85117889515